128 related articles for article (PubMed ID: 34514791)
1. Metabolic Profiling of Carbonyl Compounds for Unveiling Protective Mechanisms of
Zhang ZT; Guo N; Zhuang GD; Deng SM; He WJ; Chen ZQ; Xu YH; Tang D; Wang SM
J Agric Food Chem; 2021 Sep; 69(37):10943-10951. PubMed ID: 34514791
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of Huang-Lian-Jie-Du Decoction on diabetic nephropathy through regulating AGEs/RAGE/Akt/Nrf2 pathway and metabolic profiling in db/db mice.
Tang D; He WJ; Zhang ZT; Shi JJ; Wang X; Gu WT; Chen ZQ; Xu YH; Chen YB; Wang SM
Phytomedicine; 2022 Jan; 95():153777. PubMed ID: 34815154
[TBL] [Abstract][Full Text] [Related]
3. Targeted arginine metabolomics combined with metagenomics revealed the potential mechanism of Pueraria lobata extract in treating myocardial infarction.
Yi B; Zhao Y; Yan H; Li Z; Zhang P; Fang Z; Zhao Y; Yang H; Guo N
J Chromatogr A; 2024 Mar; 1719():464732. PubMed ID: 38387153
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics study of cadmium-induced diabetic nephropathy and protective effect of caffeic acid phenethyl ester using UPLC-Q-TOF-MS combined with pattern recognition.
Gong P; Chang X; Chen X; Bai X; Wen H; Pi S; Yang W; Wang L; Chen F
Environ Toxicol Pharmacol; 2017 Sep; 54():80-92. PubMed ID: 28704754
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant and Antiapoptotic effect of aqueous extract of Pueraria tuberosa (Roxb. Ex Willd.) DC. On streptozotocin-induced diabetic nephropathy in rats.
Shukla R; Banerjee S; Tripathi YB
BMC Complement Altern Med; 2018 May; 18(1):156. PubMed ID: 29751837
[TBL] [Abstract][Full Text] [Related]
6. Explore of the beneficial effects of Huang-Lian-Jie-Du Decoction on diabetic encephalopathy in db/db mice by UPLC-Q-Orbitrap HRMS/MS based untargeted metabolomics analysis.
He WJ; Cao DM; Chen YB; Shi JJ; Hu T; Zhang ZT; Lan T; Tang D; Wang SM
J Pharm Biomed Anal; 2021 Jan; 192():113652. PubMed ID: 33039912
[TBL] [Abstract][Full Text] [Related]
7. Identification of Nutritional Ingredients and Medicinal Components of
Shang X; Huang D; Wang Y; Xiao L; Ming R; Zeng W; Cao S; Lu L; Wu Z; Yan H
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770994
[No Abstract] [Full Text] [Related]
8. Effect of extract of Pueraria tuberosa on expression of hypoxia inducible factor-1α and vascular endothelial growth factor in kidney of diabetic rats.
Shukla R; Pandey N; Banerjee S; Tripathi YB
Biomed Pharmacother; 2017 Sep; 93():276-285. PubMed ID: 28648975
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics of the anti-inflammatory effect of Pueraria lobata and Pueraria lobata var. Thomsonii in rats.
Xi C; Zhang M; Li B; Meng X; Xu S; Du H; Wang X; Xu J; Ke H; Cui Y; Qu F
J Ethnopharmacol; 2023 Apr; 306():116144. PubMed ID: 36649849
[TBL] [Abstract][Full Text] [Related]
10. Altered metabolic profiles and targets relevant to the protective effect of acteoside on diabetic nephropathy in db/db mice based on metabolomics and network pharmacology studies.
Gao W; Gao S; Zhang Y; Wang M; Liu Y; Li T; Gao C; Zhou Y; Bian B; Wang H; Wei X; Sato T; Si N; Zhao W; Zhao H
J Ethnopharmacol; 2024 Jan; 318(Pt B):117073. PubMed ID: 37619856
[TBL] [Abstract][Full Text] [Related]
11. An extract of Pueraria tuberosa tubers attenuates diabetic nephropathy by upregulating matrix metalloproteinase-9 expression in the kidney of diabetic rats.
Tripathi YB; Shukla R; Pandey N; Pandey V; Kumar M
J Diabetes; 2017 Feb; 9(2):123-132. PubMed ID: 26924185
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic study of the protective effect of Gandi capsule for diabetic nephropathy.
Liu Y; Chen X; Liu Y; Chen T; Zhang Q; Zhang H; Zhu Z; Chai Y; Zhang J
Chem Biol Interact; 2019 Dec; 314():108815. PubMed ID: 31499054
[TBL] [Abstract][Full Text] [Related]
13. Puerarin, isolated from Pueraria lobata (Willd.), protects against diabetic nephropathy by attenuating oxidative stress.
Xu X; Zheng N; Chen Z; Huang W; Liang T; Kuang H
Gene; 2016 Oct; 591(2):411-6. PubMed ID: 27317894
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic and lipidomic study of the protective effect of Chaihuang-Yishen formula on rats with diabetic nephropathy.
Zhao T; Zhang H; Zhang X; Zhao T; Lan HY; Liang Q; Luo G; Li P
J Ethnopharmacol; 2015 May; 166():31-41. PubMed ID: 25698246
[TBL] [Abstract][Full Text] [Related]
15. Network pharmacology combined with metabolomics to study the mechanism of Shenyan Kangfu Tablets in the treatment of diabetic nephropathy.
Wang X; He Q; Chen Q; Xue B; Wang J; Wang T; Liu H; Chen X
J Ethnopharmacol; 2021 Apr; 270():113817. PubMed ID: 33444720
[TBL] [Abstract][Full Text] [Related]
16. Predictive metabolic signatures for the occurrence and development of diabetic nephropathy and the intervention of Ginkgo biloba leaves extract based on gas or liquid chromatography with mass spectrometry.
Du Y; Xu BJ; Deng X; Wu XW; Li YJ; Wang SR; Wang YN; Ji S; Guo MZ; Yang DZ; Tang DQ
J Pharm Biomed Anal; 2019 Mar; 166():30-39. PubMed ID: 30599279
[TBL] [Abstract][Full Text] [Related]
17. Pueraria tuberosa extract inhibits iNOS and IL-6 through suppression of PKC-α and NF-kB pathway in diabetes-induced nephropathy.
Shukla R; Banerjee S; Tripathi YB
J Pharm Pharmacol; 2018 Aug; 70(8):1102-1112. PubMed ID: 29770444
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Isoflavones in Pueraria by UHPLC-Q-Orbitrap HRMS and Study on α-Glucosidase Inhibitory Activity.
Yang Y; Zhao H; Zhu F; Liu X; Liu Y; Zeng F; Liu B
Foods; 2022 Nov; 11(21):. PubMed ID: 36360136
[TBL] [Abstract][Full Text] [Related]
19. Investigating the Systems-Level Effect of
Oh JH; Baek SE; Lee WY; Baek JY; Trinh TA; Park DH; Lee HL; Kang KS; Kim CE; Yoo JE
Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31752216
[TBL] [Abstract][Full Text] [Related]
20. Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy.
Zhu C; Liang QL; Hu P; Wang YM; Luo GA
Talanta; 2011 Sep; 85(4):1711-20. PubMed ID: 21872008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
